P/E của cổ phiếu BDX là bao nhiêu?

Becton Dickinson and Company (BDX) hiện giao dịch ở mức P/E 32.46 lần.

ROE của cổ phiếu BDX là bao nhiêu?

Becton Dickinson and Company có tỷ suất lợi nhuận trên vốn chủ sở hữu (ROE) 4.72%.

Tỷ suất cổ tức của BDX là bao nhiêu?

Becton Dickinson and Company có tỷ suất cổ tức 2.48%.

Điểm chất lượng (Quality Score) của BDX là bao nhiêu?

AI của chúng tôi đánh giá chất lượng tài chính tổng thể của BDX ở mức 38/100, dựa trên khả năng sinh lời, tăng trưởng, nợ và độ ổn định lợi nhuận.

Bây giờ có nên mua cổ phiếu BDX không?

Điểm AI Timing của BDX là 91/100, thể hiện mức độ hấp dẫn tương đối của giá hiện tại theo tín hiệu kỹ thuật và momentum — nên cân nhắc cùng điểm chất lượng và kế hoạch đầu tư của bạn.

Cổ phiếu BDX thuộc ngành nào?

Becton Dickinson and Company được xếp vào ngành Healthcare >> Medical Instruments & Supplies trên sàn NYSE

Cổ phiếu BDX (NYSE) | BECTON DICKINSON AND COMPANY

Stock Check Daily update data at 8:30 AM
(Price: 2026-07-31 | FS: 2026-03-31)

BDX AI Analysis Summary

Our AI summary for BDX: Becton Dickinson and Company (NYSE), Healthcare >> Medical Instruments & Supplies sector. The stock currently trades at a P/E of 32.46, ROE of 4.72%, a dividend yield of 2.48%. Its financial Quality Score stands at 38/100 — fundamentals below the market average. The AI Timing Score is 91/100 — multiple technical signals currently support price momentum. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.

BDX

Becton Dickinson and Company

USD 165.62

0.17 (0.10%) Day Change

Watchlist Portfolio Compare Chart

32.46

P/E

0.72

D/E

4.7%

ROE

2.2%

ROA

2.48%

Div Yield

-29.78

PEG

BECTON DICKINSON AND COMPANY
TYPE: STOCK
MARKET: NYSE

Compare Watchlist Myport

USD 165.62 Price 0.17 (0.10%) Day Change	NEWS SCORE: 99

BDX Chất lượng tổng thể của cố phiếu Không tốt ( Chất lượng = 38) nhưng Thời điểm mua ...(Sign In to See)...

Loading chart...

38 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: Tỷ lệ ROE tương đối thấp
[-] Tốc độ tăng trưởng ROE dưới mức tiêu chí của chúng tôi.
Lịch sử ROE tương đối thấp
ROA quá thấp so với ROE
Tốc độ tăng trưởng ROA dưới mức tiêu chí của chúng tôi.
Biên lợi nhuận ròng tương đối thấp.
Tốc độ tăng trưởng biên lợi nhuận ròng dưới mức tiêu chí của chúng tôi
Lịch sử Biên lợi nhuận ròng tương đối thấp.

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Momentum indicators aligned on the daily timeframe

Unlock timing signals and detailed reasons

Chi tiết hơn, sẽ thấy rằng các yếu tố chất lượng Không tốt , Sức khỏe tài chính Không tốt lắm , và khả năng kiếm lợi nhuận Không tốt lắm , ...

Yếu tố Chất lượng

44%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	99
Magic Formula Rank by ROA	2442
Magic Formula Rank by ROE	2442
Magic Formula Rank by ROIC	2631
Price	165.62
PBV / Sector	1.90 / 3.37
Earning Per Share	4.11

PE / Sector	32.46 / 44.25
PEG or PE/Growth / Sector	-29.78 / -1.35
Average 1M Daily Value	223.83 M GREAT
Average 1W Daily Value	254.21 M GREAT

Yếu tố Kỹ thuật

71%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Sức khỏe tài chính

58%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

Khả năng kiếm lợi nhuận

54%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	5.33 / 82.17
NPM Average (%) / Sector	7.71 / 28.91
NPM Change Average (%) / Sector	-12.05 / 208.28
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	2.24 / 7.70
ROA Average (%) / Sector	2.88 / -22.17
ROA Change Average (%) / Sector	-8.69 / 105.15
ROE (%) / Sector	4.72 / 10.10
ROE Average (%) / Sector	6.14 / 392.40
ROE Change Average (%) / Sector	-8.02 / 109.80
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

Lợi tức cho nhà đầu tư

41%

Dividend (%) / Sector	2.48 / 0.99
Dividend Average (%) / Sector	1.91 / 1.43
Dividend Change Average (%) / Sector	11.53 / 11.29 GOOD

Chi tiết đăng ký

Analyze Date	2026-08-01 07:59:32
Symbol	BDX
Name	BECTON DICKINSON AND COMPANY
Sector	Healthcare >> Medical Instruments & Supplies
Market	NYSE
Listed Shares	275.54 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	45,833.39 / 16,159.14

Tin tức, Dự báo ước tính

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 1 Becton Drive, Franklin Lakes, NJ, United States, 07417-1880

Phone: 201 847 6800

Website: https://www.bd.com

Employees: 60,000

Sector: Healthcare >> Medical Instruments & Supplies

Description: Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. It operates through Medical Essentials, Connected Care, BioPharma Systems, Interventional and Life Sciences segments. It provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication safety and infusion therapy delivery systems, medication compounding workflow system, automated medication dispensing and supply management systems, informatics and analytics and pharmacy automation system, and medication inventory optimization and tracking system; hemodynamic monitoring system; and prefillable drug delivery systems. It also offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, and microorganism identification and drug susceptibility, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent system, and solution for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. It provides hernia and soft tissue repair, biological and bioresorbable graft, biosurgery, and other surgical products; surgical infection prevention, peripheral intervention, and urology and critical care products. The company has a strategic collaboration with ChemoGLO for the advancement of hazardous drug contamination testing in health care